ICPMS-2030 Expanding solutions for elemental impurity analysis in pharmaceutical products
Shimadzu has released its new ICPMS-2030 Inductively Coupled Plasma Mass Spectrometer. It meets the requirements of the ICH Q3D guidelines for elemental impurities in pharmaceutical products. The ICPMS-2030 satisfies these requirements with ppt level high sensitivity. This is achieved by the newly developed collision cell and the optimized internal structure. During the ICPMS-2030 European Launch Tour ("Critical Mass Tour") starting March 2016, the ICPMS-2030 can be seen at several exhibitions.
For more details please visit www.shimadzu.eu
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Full Tolerance Coverage Method for Assessing Uniformity of Dosage Units with Large Sample Sizes
March 10th 2025The ‘full tolerance coverage method’ is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.
Inspiration Over Desperation: Accurant Biotech CEO Talks Leadership, Innovation, and Motivation
March 4th 2025Xiao-Yan Cai, PhD, shares insights into her leadership style, the importance of motivation in the workplace, and how she balances repetition with innovation, discussing how hobbies and resilience uniquely shape her professional approach, emphasizing the value of perseverance and preparation in both science and life.
